| scholarly article | Q13442814 |
| P50 | author | Manho Kim | Q55728067 |
| Kon Chu | Q86742155 | ||
| P2093 | author name string | Seung U Kim | |
| Jae K Roh | |||
| Hong J Lee | |||
| Seung K Kim | |||
| In H Park | |||
| Kyu C Wang | |||
| Soon T Lee | |||
| P2860 | cites work | Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 |
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| How cells respond to interferons | Q27861006 | ||
| Embryonic stem cell lines derived from human blastocysts | Q27861010 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation | Q29547561 | ||
| Amyotrophic lateral sclerosis | Q29619516 | ||
| Parkinson's disease. First of two parts | Q29620416 | ||
| Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994 | Q30544789 | ||
| Development of a tumor-selective approach to treat metastatic cancer | Q33267284 | ||
| Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model | Q33269334 | ||
| Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease | Q34320662 | ||
| Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease | Q34327144 | ||
| Medulloblastoma: clinical and biologic aspects | Q34364285 | ||
| Cell transplantation for stroke | Q34805823 | ||
| Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase | Q35693935 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 | ||
| Human neural stem cells genetically modified for brain repair in neurological disorders | Q35918287 | ||
| Interferon-beta gene therapy for cancer: basic research to clinical application | Q35951885 | ||
| Parkinson's disease: pathophysiology | Q36495393 | ||
| Excitotoxic injury of the neostriatum: a model for Huntington's disease | Q36586040 | ||
| Derivation of pluripotent stem cells from cultured human primordial germ cells | Q36797341 | ||
| Gene therapy clinical trials worldwide to 2007--an update. | Q36920192 | ||
| Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors | Q68701451 | ||
| Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid | Q72098398 | ||
| Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11 | Q74027589 | ||
| Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain | Q74284095 | ||
| Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke | Q80399919 | ||
| Stem cell-based cell therapy for Huntington disease: a review | Q37028233 | ||
| Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. | Q38922636 | ||
| Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma | Q38961512 | ||
| Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma | Q38972984 | ||
| Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma | Q39180978 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| Production and characterization of immortal human neural stem cell line with multipotent differentiation property | Q39998097 | ||
| Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling | Q40002631 | ||
| Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma | Q40131868 | ||
| Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model | Q40184078 | ||
| Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. | Q40202809 | ||
| Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease | Q40278367 | ||
| Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease | Q40356743 | ||
| Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia | Q40366934 | ||
| PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model | Q40382315 | ||
| Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | Q40394957 | ||
| GDNF delivery using human neural progenitor cells in a rat model of ALS. | Q40425197 | ||
| Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease | Q40543499 | ||
| Human neural stem cells: electrophysiological properties of voltage-gated ion channels | Q40712044 | ||
| Parkinson's disease. Second of two parts | Q40840040 | ||
| Regulation of dopamine production by genetically modified primary fibroblasts | Q41061107 | ||
| Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase. | Q41124067 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery | Q41450648 | ||
| Amyotrophic lateral sclerosis: concepts in pathogenesis and etiology | Q41467047 | ||
| In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors | Q42818740 | ||
| Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 | ||
| Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. | Q43829335 | ||
| Adenosine triphosphate induces proliferation of human neural stem cells: Role of calcium and p70 ribosomal protein S6 kinase | Q44401723 | ||
| Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats | Q45063826 | ||
| Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model | Q45296899 | ||
| Stem and progenitor cell-based therapy of the human central nervous system. | Q45297477 | ||
| Motor and cognitive improvements in patients with Huntington's disease after neural transplantation | Q45301920 | ||
| Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse | Q45869109 | ||
| Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts | Q45877347 | ||
| Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta | Q45885532 | ||
| Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice | Q45887127 | ||
| Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 | ||
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1alpha stabilization in the host brain | Q46677723 | ||
| VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model | Q47427098 | ||
| Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 | ||
| Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage | Q48244314 | ||
| Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia | Q48304910 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 27-35 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | International journal of stem cells | Q26842430 |
| P1476 | title | Human nerual stem cells for brain repair | |
| P478 | volume | 1 |
| Q33614806 | Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease |
| Q99207673 | Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients |
| Q33614830 | In Vitro Differentiation and Expansion of Intrathymic T Cell Progenitors from Human Umbilical Cord Blood-Derived CD34(+) Cells |
Search more.